Press-release for stocks related to als

Prices are updated after-hours

tags : Als crawled time : 18:00

save search

Clene's Nanocrystal ALS Treatment Bounces Back with Positive Data
Published: 2023-03-09 (Crawled : 18:00) - biospace.com/
CLNN 4 | $0.3352 0.66% 0.66% 310K

| -73.85% | O: 10.0% H: 0.7% C: -5.59%
treatment als back positive

Amylyx Pharmaceuticals Announces Publication of New CENTAUR Trial Analyses Further Demonstrating Significant Survival Benefit with AMX0035 in People with ALS
Published: 2022-05-05 (Crawled : 18:00) - biospace.com/
AMLX A | $1.945 -1.77% -1.8% 1.5M

| -80.73% | O: -0.79% H: 1.1% C: -7.57%
amx0035 als trial publication

Fusion Pharmaceuticals Announces Fourth Quarter 2021 Financial Results and Clinical Program Updates
Published: 2022-03-17 (Crawled : 18:00) - biospace.com/
FUSN | $21.42 0.47% 0.47% 1.9M

Health Technology

| 204.69% | O: 4.27% H: 6.82% C: 6.82%
als financial results program results

Virpax Pharmaceuticals Expands AnQlar™ Development and Commercialization Rights Through Worldwide Licensing Agreement
Published: 2022-03-15 (Crawled : 18:00) - biospace.com/
VRPX | $3.155 -4.39% -4.6% 11K

| 66.32% | O: 8.42% H: 11.16% C: -2.43%
als commercialization virpax license

Global Cathode Materials Market Report 2022
Published: 2022-03-11 (Crawled : 18:00) - prnewswire.com
PKX | News | $71.48 -0.17% 0.0% 89K

Non-Energy Minerals

| 24.57% | O: 0.73% H: 0.0% C: 0.0%
als report market

Processa Pharmaceuticals CEO Dr. David Young To Present at the Oppenheimer 32nd Annual Healthcare Conference
Published: 2022-03-10 (Crawled : 18:00) - biospace.com/
PCSA | $1.53 -2.27% 25K

Producer Manufacturing

| -59.85% | O: -1.38% H: 0.0% C: 0.0%
health als thc ceo conference

General Dynamics Chairman and CEO to speak at the 2022 J.P. Morgan Industrials Conference
Published: 2022-03-08 (Crawled : 18:00) - prnewswire.com
GD | $292.72 0.48% 0.78% 1.1M

Electronic Technology

| 18.37% | O: 0.04% H: 0.19% C: -4.88%
als air trials ceo trial conference

LyondellBasell to Address J.P. Morgan Industrials Conference
Published: 2022-03-08 (Crawled : 18:00) - prnewswire.com
LYB | $100.55 -0.04% 0.0% 1.1M

Process Industries

| 3.65% | O: -1.62% H: 2.5% C: 0.59%
als trials trial conference

Tonix Pharmaceuticals Announces Collaboration with Massachusetts General Hospital to Evaluate TNX-1900 (Intranasal Potentiated Oxytocin) for Treating Binge Eating Disorder
Published: 2022-03-07 (Crawled : 18:00) - biospace.com/
TNXP | $0.1574 1.29% 1.27% 1.6M

Health Technology

| -22.71% | O: 5.17% H: 1.06% C: -8.08%
tnx-1900 als order announces collaboration collaboration set oxytocin potential

AAON to Present at J.P. Morgan Industrials Conference
Published: 2022-03-04 (Crawled : 18:00) - globenewswire.com
AAON F | $88.5 2.04% 2.0% 450K

Producer Manufacturing

| 63.97% | O: -1.58% H: 0.0% C: 0.0%
als trials trial conference

The CUMULUS MEDIA | Westwood One Audio Active Group® Reveals New Advertiser and Consumer Studies on Media Attentiveness and Ad Skipping
Published: 2022-02-28 (Crawled : 18:00) - globenewswire.com
CMLS | $2.725 0.93% 0.92% 68K

Consumer Services

| -75.12% | O: -0.09% H: 6.46% C: 5.72%
group als audio media active one

Global Precious Metals Market (2022 to 2027) - Industry Trends, Share, Size, Growth, Opportunity and Forecasts
Published: 2022-02-25 (Crawled : 18:00) - prnewswire.com
GFI | News | $16.89 1.38% 0.0% 2.7M

Non-Energy Minerals

| 27.28% | O: -1.43% H: 0.0% C: 0.0%
AG | $6.82 4.12% 0.0% 8.4M

Non-Energy Minerals

| -39.96% | O: -1.94% H: 0.0% C: 0.0%
GOLD | $16.69 1.64% 0.0% 27M

Non-Energy Minerals

| -28.77% | O: -5.85% H: 0.0% C: 0.0%
GOLD | $16.69 1.64% 0.0% 27M

Non-Energy Minerals

| -28.77% | O: -5.85% H: 0.0% C: 0.0%
als growth

Rhythm Pharmaceuticals Announces FDA Extension of Review Period for IMCIVREE® (setmelanotide) for Patients with Bardet-Biedl Syndrome and Alström Syndrome
Published: 2022-02-24 (Crawled : 18:00) - biospace.com/
RYTM A | $39.945 2.4% 2.34% 410K

Health Technology

| 377.9% | O: -10.16% H: 1.13% C: -3.46%
imcivree fda als setmelanotide set pdufa syndros

MyMD Pharmaceuticals Enrolls First Patient in Phase 2 Clinical Trial of MYMD-1 as a Therapy for Delaying Aging and Extending Healthy Lifespan
Published: 2022-02-23 (Crawled : 18:00) - biospace.com/
MYMD | $2.575 -0.19% -0.19% 23K

Manufacturing

| -37.71% | O: 0.49% H: 2.91% C: -9.93%
health phase 2 als trial therapy enroll

Phio Pharmaceuticals Initiates In Vivo Studies of INTASYL Based Antivirals Against SARS-CoV-2
Published: 2022-02-22 (Crawled : 18:00) - biospace.com/
PHIO | News | $0.6709 -19.16% -23.7% 640K

Health Technology

| -16.03% | O: 1.97% H: 1.18% C: -3.04%
als sars-cov-2 antiviral

Actinium Pharmaceuticals, Inc. and AVEO Oncology Enter Research Collaboration Agreement to Develop First-in-Class Actinium-225 ErbB3 Targeting Radiotherapy for Solid Tumors
Published: 2022-02-22 (Crawled : 18:00) - biospace.com/
AVEO | $15.0 0.0% 0

Health Technology

| 338.45% | O: -0.58% H: 1.18% C: -1.18%
ATNM | $6.96 -2.93% -1.14% 190K

Health Technology

| 37.01% | O: -1.18% H: 3.39% C: 0.2%
als solid tumors research therapy collaboration iot

Global Metals in Electric Vehicle Charging Infrastructure Market to accumulate US$ 10 Bn by 2032 - Latest Fact.MR Study
Published: 2022-02-21 (Crawled : 18:00) - prnewswire.com
AA | $36.06 -0.8% 0.0% 7.4M

Non-Energy Minerals

| Email alert Add to watchlist
als charging test electric vehicle

“Sleep Pathfinder Mission” Recent 31 Day Study by Balanced Health Botanicals finds CBDistillery’s Cannabinoid Combo of CBD and CBN Amplifies the Entourage Effect
Published: 2022-02-16 (Crawled : 18:00) - villagefarms.com
VFF | $1.37 13.22% 11.68% 1.3M

Process Industries

| -75.8% | O: -1.59% H: 3.05% C: 1.97%
day health als cbd

Compass Minerals Presents the Big 12 Basketball Food Drive
Published: 2022-02-15 (Crawled : 18:00) - compassminerals.com
PSX | News | $158.84 1.14% 0.0% 1.8M

Energy Minerals